# Oral Diseases and Disorders Research (93.121)

Source: https://welltoldgrants.com/programs/93-121-oral-diseases-and-disorders-research/  
Publisher: Well Told Grants. Data: USAspending.gov and Grants.gov, updated October 31, 2026.

Oral Diseases and Disorders Research is run by Department of Health and Human Services. From fiscal 2021 to 2025 it awarded $1.9 billion in 2,263 grants, about $818,037 per award.

## Objectives

NIDCR extramural research provides research funds to support basic, translational, and clinical research in dental, oral, and craniofacial health and disease through grants, cooperative agreements, including small business research through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs and contracts that support scientists working in institutions throughout the United States and internationally. Extramural programs plan, develop, and manage scientific priorities through portfolio analyses and consultation with stakeholders, encouraging the most promising discoveries and emerging technologies for rapid translation to clinical applications. The Integrative Biology and Infectious Diseases programs support basic and translational research programs on oral microbiology; salivary biology and immunology; oral and salivary gland cancers; neuroscience of orofacial pain and temporomandibular disorders; mineralized tissue physiology; dental biomaterials; and tissue engineering and regenerative medicine. The branch aims to accelerate progress in basic and translational research in these areas, and further stimulate the discovery pipeline based on clinical needs. The Translational Genomics Research programs support basic and translational research in genetics, genomics, developmental biology, and data science toward the goal of improving dental, oral, and craniofacial health. The focus is on deciphering the genetic, molecular, and cellular mechanisms underlying dental, oral, and craniofacial development and anomalies. The Behavioral and Social Sciences Research programs support basic and applied research to promote oral health, to prevent oral diseases and related disabilities, and to improve management of craniofacial conditions, disorders, and injury. The program prioritizes mechanistic research that contributes to a cumulative science of behavior change, to maximize the rigor, relevance, and dissemination of efficacious behavior change interventions. The Clinical Research programs supports patient-oriented, population, and community based research aimed at improving the dental, oral, and craniofacial health of the nation. The Center focuses on a variety of diseases and conditions through clinical trials, epidemiologic studies, practice-based research, the HIV/AIDS and oral health program, and studies of oral health disparities and inequities in all areas of NIDCR programmatic interest. The program encourages investigations that have the potential to translate findings into evidence-based clinical applications. The Research Training and Career Development extramural programs span the career stages of scientists, supporting research training and career development for PhD and dual degree DDS/DMD-PhD students, postdoctoral scholars and early career, midcareer, and established investigators. The programs manage support for fellowships, research training grants, career development and career transition awards, NIH loan repayment awards, and diversity supplements to support research experiences for high school students through investigators. Extramural programs are accountable for the efficient and effective use of taxpayer funds to support research on dental, oral, and craniofacial diseases and disorders and improving the oral health of all Americans. Extramural programs support research and research training to establish the foundation for scientific discoveries that include transparent and rigorous planning, priority setting, continuous and consistent reviews of progress, and focus on the development of a diverse, highly skilled, and nimble workforce that can rapidly respond to scientific breakthroughs and public health challenges. Extramural programs employ evaluation domains, from needs assessment and strategic planning to implementation and process evaluation, performance measurement, and outcomes and impact analysis to evaluate strategic objectives.

## Funding by fiscal year

| Year | Amount | Awards |
|---|---|---|
| 2021 | $348 million | 1,030 |
| 2022 | $365 million | 1,078 |
| 2023 | $380 million | 1,076 |
| 2024 | $379 million | 1,053 |
| 2025 | $379 million | 1,014 |

## Largest recipients

| Recipient | State | Amount |
|---|---|---|
| Regents of the University of Michigan | Michigan | $89.2 million |
| The Regents of the University of California, San Francisco | California | $80.8 million |
| University of Southern California | California | $78.6 million |
| University of Pittsburgh - of the Commonwealth System of Higher Education | Pennsylvania | $55.6 million |
| The Trustees of the University of Pennsylvania | Pennsylvania | $51.5 million |
| University of California, Los Angeles | California | $50.1 million |
| Ada Forsyth Institute, Inc. | Massachusetts | $49.9 million |
| University of Florida | Florida | $47.1 million |
| University of Texas Health Science Center at Houston | Texas | $41.7 million |
| University of North Carolina at Chapel Hill | North Carolina | $36.9 million |
| University of Alabama at Birmingham | Alabama | $34.6 million |
| Oregon Health & Science University | Oregon | $33.0 million |
| The Research Foundation for the State University of New York | New York | $29.8 million |
| The University of Iowa | Iowa | $28.0 million |
| University of Maryland, Baltimore | Maryland | $26.8 million |
| The Leland Stanford Junior University | California | $26.6 million |
| Virginia Commonwealth University | Virginia | $26.6 million |
| The Regents of the University of Colorado | Colorado | $25.3 million |
| University of Illinois | Illinois | $24.9 million |
| University of Washington | Washington | $23.6 million |

## Open opportunities

- [Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-095-secondary-analysis-and-integration-of-existing-data-to/), closes November 6, 2026
- [Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-370-ethical-legal-and-social-implications-elsi-small-research/), closes November 16, 2026
- [Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/par-25-096-secondary-analysis-and-integration-of-existing-data-to/), closes November 17, 2026
- [Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-369-ethical-legal-and-social-implications-elsi-exploratory/), closes November 18, 2026
- [HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-at-25-003-heal-initiative-pain-research-enhancement-program-prep-r15/), closes November 23, 2026
- [Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)](https://welltoldgrants.com/grants/rfa-od-27-008-maximizing-the-scientific-value-of-data-generated-by/), closes December 2, 2026
- [Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-296-emerging-global-leader-award-k43-independent-clinical-trial/), closes December 3, 2026
- [NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-24-011-nih-research-software-engineer-rse-award-r50-clinical/), closes December 4, 2026
- [Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-098-interventions-to-expand-cancer-screening-and-preventive/), closes January 7, 2027
- [Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-378-intervention-research-to-improve-native-american-health-r34/), closes January 7, 2027
- [Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-379-intervention-research-to-improve-native-american-health-r01/), closes January 7, 2027
- [HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-ns-25-023-heal-initiative-studies-to-enable-analgesic-discovery-r61/), closes January 15, 2027
- [Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-24-268-biomedical-research-environment-and-sponsored-programs/), closes January 27, 2027
- [NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-lm-28-001-nlm-institutional-grants-for-research-training-in-biomedical/), closes February 11, 2027
- [NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-100-nih-cdc-and-fda-small-business-innovation-research/), closes April 5, 2027
- [NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-27-102-nih-small-business-technology-transfer-grant-parent-sttr/), closes April 5, 2027
- [Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/rfa-od-25-003-short-courses-on-innovative-methodologies-and-approaches-in/), closes April 9, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-185-mentored-patient-oriented-research-career-development-award/), closes May 7, 2027
- [Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-191-mentored-quantitative-research-development-award-parent-k25/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-175-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-176-mentored-research-scientist-development-award-parent-k01/), closes May 7, 2027
- [Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-179-independent-scientist-award-parent-k02-independent-clinical/), closes May 7, 2027
- [NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-194-nih-pathway-to-independence-award-parent-k99-r00/), closes May 7, 2027
- [Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)](https://welltoldgrants.com/grants/par-26-001-screening-brief-intervention-and-referral-to-treatment-or/), closes May 7, 2027
- [Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)](https://welltoldgrants.com/grants/pa-24-184-mentored-patient-oriented-research-career-development-award/), closes May 8, 2027
- [Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-24-182-mentored-clinical-scientist-research-career-development/), closes May 8, 2027
- [Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-211-enhancing-mechanistic-research-on-precision-probiotic/), closes June 2, 2027
- [Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-210-enhancing-mechanistic-research-on-precision-probiotic/), closes June 2, 2027
- [Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-254-change-of-recipient-organization-type-7-parent-clinical/), closes July 12, 2027
- [Successor-in-Interest (Type 6 Parent Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-24-253-successor-in-interest-type-6-parent-clinical-trial/), closes July 17, 2027
- [Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-24-293-blueprint-neurotherapeutics-network-bpn-biologic-based-drug/), closes August 18, 2027
- [NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-080-nih-support-for-conferences-and-scientific-meetings-parent/), closes September 7, 2027
- [Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-296-limited-competition-clinical-and-translational-science/), closes October 19, 2027
- [Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-122-pilot-projects-investigating-understudied-proteins/), closes November 16, 2027
- [Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-062-continuation-or-revision-of-nidcr-clinical-trial-planning/), closes January 6, 2028
- [NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-057-nidcr-drug-biologic-device-and-or-procedure-intervention/), closes January 6, 2028
- [NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)](https://welltoldgrants.com/grants/par-25-188-nidcr-behavioral-and-social-intervention-clinical-trial/), closes January 6, 2028
- [Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-144-dissemination-and-implementation-research-in-health-r01/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-233-dissemination-and-implementation-research-in-health-r03/), closes January 7, 2028
- [Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-185-screening-and-functional-validation-of-genomic-variants/), closes January 7, 2028
- [Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-143-dissemination-and-implementation-research-in-health-r21/), closes January 7, 2028
- [NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-027-nidcr-dentist-scientist-career-transition-award-for/), closes January 7, 2028
- [NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-105-nidcr-small-grant-program-for-new-investigators-r03/), closes January 7, 2028
- [Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-134-academic-research-enhancement-award-area-for-undergraduate/), closes January 7, 2028
- [Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-298-research-enhancement-award-program-reap-for-health/), closes January 7, 2028
- [Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-346-exploratory-developmental-bioengineering-research-grants/), closes January 7, 2028
- [NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-304-nih-exploratory-developmental-research-project-grant-parent/), closes January 7, 2028
- [NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-25-301-nih-research-project-grant-parent-r01-clinical-trial/), closes January 7, 2028
- [Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-338-academic-industrial-partnerships-for-translation-of/), closes January 7, 2028
- [Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)](https://welltoldgrants.com/grants/par-25-383-blueprint-medtech-translator-ug3-uh3-clinical-trial-optional/), closes January 28, 2028
- [Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-442-expanding-the-target-landscape-by-drugging-the-undruggable/), closes February 17, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)](https://welltoldgrants.com/grants/pa-25-168-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 4, 2028
- [NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-333-nidcr-dual-degree-dentist-scientist-pathway-to-independence/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)](https://welltoldgrants.com/grants/pa-25-423-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-425-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)](https://welltoldgrants.com/grants/pa-25-426-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)](https://welltoldgrants.com/grants/pa-25-424-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)](https://welltoldgrants.com/grants/pa-25-422-ruth-l-kirschstein-national-research-service-award-nrsa/), closes May 7, 2028
- [INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-od-27-003-include-project-exploratory-developmental-research-awards/), closes June 15, 2028
- [INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-od-27-004-include-project-transformative-research-awards-for-down/), closes June 15, 2028
- [Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-076-lasker-clinical-research-scholar-s-program-si2-r00/), closes July 7, 2028
- [Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-096-grants-for-early-medical-surgical-specialists-transition-to/), closes July 16, 2028
- [Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-322-stephen-i-katz-early-stage-investigator-research-project/), closes August 25, 2028
- [Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-414-support-for-research-excellence-sure-award-r16-clinical/), closes September 7, 2028
- [Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-25-415-support-for-research-excellence-first-independent-research/), closes September 7, 2028
- [Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-015-community-based-participatory-research-to-advance-data-and/), closes November 16, 2028
- [Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-001-administrative-supplements-to-existing-nih-grants-and/), closes November 30, 2028
- [Limited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-067-limited-competition-instrumentation-grant-program-for/), closes January 26, 2029
- [SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-098-sbir-sttr-commercialization-readiness-pilot-crp-program/), closes April 5, 2029
- [Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-037-predoctoral-to-postdoctoral-transition-award-parent-f99-k00/), closes April 8, 2029
- [NIH Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-051-nih-brain-development-cohorts-nbdc-and-population-assessment/), closes April 17, 2029
- [NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-036-nih-research-education-program-research-experiences-parent/), closes May 5, 2029
- [NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-035-nih-research-educational-program-mentoring-activities/), closes May 5, 2029
- [NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)](https://welltoldgrants.com/grants/pa-26-002-nih-collaborative-international-research-project-parent-pf5/), closes May 7, 2029
- [NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-077-nih-science-education-partnership-award-sepa-r25-clinical/), closes May 25, 2029
- [NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/pa-27-034-nih-research-education-program-courses-curriculum-methods/), closes May 25, 2029
- [Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-28-090-centers-for-aids-research-cfar-and-developmental-centers/), closes May 25, 2029
- [Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)](https://welltoldgrants.com/grants/rfa-ai-27-018-implementation-science-to-advance-hiv-prevention-treatment/), closes June 20, 2029
- [NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-058-nidcr-prospective-observational-or-biomarker-validation/), closes July 5, 2029
- [Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-057-causal-hypotheses-on-the-oral-systemic-health-impacts/), closes July 5, 2029
- [Institutional Mentored Career Development Award (Parent K12) (Clinical Trials Not Allowed)](https://welltoldgrants.com/grants/pa-27-030-institutional-mentored-career-development-award-parent-k12/), closes July 12, 2029
- [Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/par-27-062-academic-career-excellence-ace-award-k32-independent/), closes July 12, 2029
- [Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)](https://welltoldgrants.com/grants/par-28-022-specialized-programs-of-research-excellence-spores-in-human/), closes September 25, 2029
- [Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-003-collaborative-program-grant-for-interdisciplinary-teams-rm1/), closes September 26, 2029
- [NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)](https://welltoldgrants.com/grants/rfa-eb-28-004-nexttech-translational-development-of-next-generation/), closes December 1, 2030
- [Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-039-small-business-transition-grant-for-new-entrepreneurs-parent/), closes not stated
- [Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional)](https://welltoldgrants.com/grants/par-27-040-small-business-transition-grant-for-new-entrepreneurs-parent/), closes not stated
- [Investigator-Focused Award (Parent R35)](https://welltoldgrants.com/grants/par-28-037-investigator-focused-award-parent-r35/), closes not stated